Named on one round in the feed.
Since 2018-08-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Rakuten Medical Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers. | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2018-08-23 | [ LEAD ] |
No one else named on these rounds.
No sector on record.